Keyphrases
Myelitis
100%
Rheumatologic Diseases
100%
Single-center Study
100%
Lupus
100%
Aquaporin-4 IgG
63%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
36%
Multiple Sclerosis
27%
Behet's Disease
27%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
27%
Double Seronegative
27%
Myelin Oligodendrocyte Glycoprotein IgG
27%
Systemic Lupus Erythematosus
18%
Sjgren's Syndrome
18%
Rheumatologic
18%
Electronic Medical Records
18%
Connective Tissue Dysplasia
18%
Clinically Significant
9%
Disease Groups
9%
Etiology
9%
Rheumatoid Arthritis
9%
Inclusion Criteria
9%
Johns Hopkins
9%
Cell-based
9%
Functional Outcome
9%
Comorbidity
9%
Chart Review
9%
Partial Recovery
9%
Cord
9%
Associated Diseases
9%
Retrospective Cohort
9%
Psoriatic Arthritis
9%
Antiphospholipid Antibody Syndrome
9%
Oligoclonal Bands
9%
Myelopathy
9%
Longitudinally Extensive
9%
Medicine and Dentistry
Transverse Myelitis
100%
Lupus Erythematosus
100%
Diseases
100%
Aquaporin 4
63%
Neuromyelitis Optica
36%
Multiple Sclerosis
27%
Myelin Oligodendrocyte Glycoprotein
27%
Systemic Lupus Erythematosus
18%
Connective Tissue Disease
18%
Electronic Patient Record
18%
Cerebrospinal Fluid
9%
Immunotherapy
9%
Identified Patient
9%
Medicine
9%
Spinal Cord Disease
9%
Rheumatoid Arthritis
9%
Antiphospholipid Antibody
9%
Oligoclonal Band
9%
Psoriatic Arthritis
9%
Comorbidity
9%
Inflammatory Arthritis
9%
Immunology and Microbiology
Lupus Erythematosus
100%
Transverse Myelitis
100%
Myelitis
100%
Aquaporin
63%
Neuromyelitis Optica
36%
Multiple Sclerosis
27%
Myelin Oligodendrocyte Glycoprotein
27%
Systemic Lupus Erythematosus
18%
Electronic Medical Record
18%
Undifferentiated Connective Tissue Disease
18%
Cerebrospinal Fluid
9%
Inflammatory Arthritis
9%
Immunotherapy
9%
Oligoclonal Band
9%
Psoriatic Arthritis
9%
Comorbidity
9%
Antiphospholipid Antibody
9%
Neuroscience
Myelitis
100%
Transverse Myelitis
100%
Lupus Erythematosus
100%
Aquaporin 4
63%
Neuromyelitis Optica
36%
Multiple Sclerosis
27%
Myelin Oligodendrocyte Glycoprotein
27%
Systemic Lupus Erythematosus
18%
Connective Tissue
18%
Immunotherapy
9%
Spinal Cord Disease
9%
Rheumatoid Arthritis
9%
Cell-Based Assays
9%
Oligoclonal Band
9%
Phospholipid Antibody
9%
Comorbidity
9%